0
Articles |

Antithrombotic Therapy in Patients Undergoing Percutaneous Coronary Intervention

Jeffrey J. Popma, MD; E. Magnus Ohman, MD, FCCP; Jeffrey Weitz, MD; A. Michael Lincoff, MD; Robert A. Harrington, MD; Peter Berger, MD
Author and Funding Information

Correspondence to: Jeffrey J. Popma, MD, Director, Interventional Cardiology, Brigham and Women’s Hospital, 75 Francis St, L-2 Catheterization Laboratory, Boston, MA 02115; e-mail: jpopma@partners.org



Chest. 2001;119(1_suppl):321S-336S. doi:10.1378/chest.119.1_suppl.321S
Text Size: A A A
Published online

Extract

Coronary angioplasty was performed in > 700,000 patients in the United States in 1999, exceeding the number of patients undergoing coronary artery bypass graft (CABG) surgery. The expanded growth of coronary angioplasty in patients with coronary artery disease (CAD) is attributable to major advances in interventional technology over the past several years, the most notable of which are the availability of coronary stents and the adjunct use of potent antithrombotic agents during percutaneous coronary intervention (PCI), including the use of platelet glycoprotein (GP)-IIb/IIIa inhibitors.

First Page Preview

View Large
First page PDF preview

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
Antithrombotic Therapy for Non–ST-Segment Elevation Acute Coronary Syndromes*: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
PubMed Articles
Guidelines
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543